Skip to main content
Log in

Tryptamine in the Blood and Urine of a Patient with a Carcinoid Tumour

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

PATIENTS with the carcinoid syndrome typically show high blood levels of 5-hydroxytryptamine and increased urinary excretion of 5-hydroxyindolyl-3-acetic acid. Variants of the tumour have, however, been described in which the major secretion is 5-hydroxytryptophan1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oates, J. A., and Sjoerdsma, A., Amer. J. Med., 32, 333 (1962).

    Article  CAS  Google Scholar 

  2. Hess, S. M., and Undenfriend, S., J. Exp. Pharm. and Therap., 127, 175 (1959).

    CAS  Google Scholar 

  3. Sjoerdsma, A., Oates, J. A., Zaltzman, P., and Undenfriend, S., J. Exp. Pharm. and Therap., 126, 217 (1959).

    CAS  Google Scholar 

  4. Weissbach, H., King, W., Sjoerdsma, A., and Undenfriend, S., J. Biol. Chem., 234, 181 (1959).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ECCLESTON, D., CRAWFORD, T. & ASHCROFT, G. Tryptamine in the Blood and Urine of a Patient with a Carcinoid Tumour. Nature 197, 502–503 (1963). https://doi.org/10.1038/197502a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/197502a0

  • Springer Nature Limited

This article is cited by

Navigation